Form 4: Core Scientific Executive Sells 10,000 Shares

Chief Legal and Administrative Officer Todd DuChene sold 10,000 shares of Core Scientific common stock via a 10b5-1 plan.

Summary

• Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc. (CORZ), sold 10,000 shares of common stock.
• The sale occurred on May 26, 2026, at a weighted average price of $26.254 per share.
• The transaction was executed under a Rule 10b5-1 trading plan adopted on December 5, 2025.
• Following the transaction, the reporting person retains beneficial ownership of 2,088,895 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed via a pre-planned 10b5-1 arrangement, which is a standard administrative action for corporate officers.

Positives

• The sale was conducted under a pre-established Rule 10b5-1 trading plan, which is designed to avoid concerns regarding insider trading.

Negatives

• The transaction represents a divestment of equity by a key member of the executive leadership team.

Risks

• None explicitly stated in this Form 4 filing.

Future Outlook

No forward-looking guidance provided in this document.

Industry Context

StockSavvy.ai notes that routine insider selling under 10b5-1 plans is common practice for executives in the volatile cryptocurrency mining and data center infrastructure sector, often used for liquidity or tax planning rather than signaling a lack of confidence in the company's future.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives at publicly traded companies to manage equity holdings while maintaining regulatory compliance.

Stakeholder Impact

• Minimal impact expected as the sale represents a small fraction of the executive's total holdings.

Key Dates

Keywords

Core Scientific, CORZ, Insider Trading, Form 4, SEC Filing, Todd DuChene